The Lead Discovery Center (LDC) is a translational drug discovery company which takes on promising early-stage projects from academia and transforms them into innovative pharmaceutical leads that address unmet medical needs.
In close collaboration with high profile partners from academia and industry, LDC is building a strong and growing portfolio of preclinical assets with exceptional medical and commercial potential.
LDC sustains a strong partnership with the Max Planck Society and has formed alliances with Arix, AstraZeneca, Atlas, Bayer, Boehringer Ingelheim, Daiichi Sankyo, Grünenthal, Johnson & Johnson, Merck, Qurient, SOTIO & Roche as well as leading academic drug discovery centers around the globe.
The LDC offers core expertise in Cellular Biology, Assay Development & Screening, Pharmacology, Medicinal Chemistry and Therapeutic Antibody Development in a collaborative risk-sharing model. LDC has no indication limitation while projects benefit from the pathobiological know-how of its wide network into academia and clinic. The LDC team consists of industry-trained experts with solid experience in project management and drug discovery.
Lead Discovery Center GmbH
Otto-Hahn-Str. 15
44227 Dortmund, Germany
and
Semmelweisstraße 5
82152 Planegg, Germany
Website: www.lead-discovery.de